Challenging the FDA's authority to regulate autologous adult stem cells for therapeutic use: Celltex therapeutics' partnership with RNL Bio, substantial medical risks, and the implications of United States v. Regenerative Sciences.

Health matrix (Cleveland, Ohio : 1991)

Volumn 23, Issue 2, 2013, Pages 493-535

  Drabiak Syed, Katherine ^a  

^a Indiana University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AUTOTRANSPLANTATION; FOOD AND DRUG ADMINISTRATION; GOVERNMENT REGULATION; HUMAN; LEGAL ASPECT; LEGISLATION AND JURISPRUDENCE; MESENCHYMAL STEM CELL TRANSPLANTATION; UNITED STATES;

ADULT; GOVERNMENT REGULATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84894476142     PISSN: 0748383X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)